PreMD Inc. Stock

Stocks

PREMF

CA74047Y1051

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for PreMD Inc. -.--% -

Valuation: PreMD Inc.

Market Cap 461K 403K 372K 344K 654K 43.74M 664K 4.46M 1.73M 21.59M 1.73M 1.69M 74.61M P/E 2006
-5.86x
P/E 2007 -5.08x
Enterprise Value 4.9M 4.29M 3.95M 3.66M 6.95M 465M 7.06M 47.36M 18.42M 229M 18.39M 17.99M 793M EV / Sales 2006
11,468,067x
EV / Sales 2007 399,046,792x
Free-Float
70.7%
Yield 2006 *
-
Yield 2007 -
Manager TitleAgeSince
Chief Executive Officer 65 1992-11-08
Director TitleAgeSince
Director/Board Member 65 1992-11-08
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 38
-0.80%+1.38%+12.40%+82.31% 48.12B
-3.08%+3.29%+65.80%+113.96% 37.36B
-1.38%-2.29%-5.21%+40.28% 12.36B
-0.43%+3.18%+14.94%+97.17% 12.12B
+0.38%+2.76%+34.19%+120.25% 9.14B
-2.52%-0.66%+19.22%+44.22% 7.21B
+1.24%+4.23%+58.03%-1.50% 7.14B
-1.82%+0.88%+19.55%+222.63% 6.73B
-2.81%+17.66%-18.38%+20.93% 6.35B
Average -1.12%+3.65%+22.28%+82.25% 14.65B
Weighted average by Cap. -1.45%+3.82%+27.65%+88.26%

Financials

2006 2007
Net sales 3.34 2.92 2.69 2.49 4.73 316.55 4.81 32.25 12.54 156.23 12.52 12.25 539.98 0.09 0.08 0.08 0.07 0.13 8.97 0.14 0.91 0.36 4.43 0.35 0.35 15.3
Net income -5.95M -5.21M -4.8M -4.45M -8.44M -565M -8.58M -57.53M -22.37M -279M -22.33M -21.85M -963M -6.32M -5.53M -5.09M -4.72M -8.96M -599M -9.11M -61.08M -23.75M -296M -23.71M -23.2M -1.02B
Net Debt 3.07M 2.69M 2.48M 2.3M 4.36M 292M 4.43M 29.73M 11.56M 144M 11.54M 11.29M 498M 4.44M 3.88M 3.58M 3.32M 6.3M 421M 6.4M 42.91M 16.69M 208M 16.66M 16.3M 718M
Logo PreMD Inc.
PreMD Inc is a Canada-based medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Company’s products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The Company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Company’s ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has a number of products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.
Employees
-
  1. Stock Market
  2. Stocks
  3. PREMF Stock